Predictors of Hospitalization Cost in Infants with Hypoglycemia
Journal of Pediatrics & Neonatal Biology · 2018
DOI: 10.33140/jpnb.03.01.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatrics & Neonatal Biology, 2018. Die Arbeit nennt 78 Literaturangaben.
Abstract (Originalsprache)
This study sought to determine the overall hospital cost estimates in neonates with hypoglycemia, compare hospital cost in premature and non-premature neonates, and identify predictors of increased hospital cost. The median (interquartile range) cost estimate in premature and non-premature neonates were $12,755 ($4,550-$30,339) and $2,360 ($1,153-$3,736), respectively. Increased cost was observed, when more than five procedures was performed during the same hospitalization (OR 10.13, 95 % CI 8.67-11.83, P < 0.0001), when hospital bed size medium (OR 1.37, 95 % CI 1.16-1.61, P =0.0002) or ≥ 400 (OR 1.65, 95 % CI 1.41-1.92, P < 0.0001), when hospital length of stay exceeded 15 days (OR 44.97, 95 % CI 41.49- 48.73, P < 0.0001), in teaching hospitals (OR 1.97, 95 % CI 1.82-2.13, P < 0.0001), in of the presence of chronic conditions (OR 2.46, 95 % CI 2.27-2.66, P < 0.0001), comorbidities (OR 2.11, 95 % CI 1.90-2.35, P < 0.0001), prematurity (OR 2.39, 95 % CI 2.20-2.60, P < 0.0001), and death (OR 2.95, 95 % CI 2.13-4.09, P < 0.0001). Neonates with hypoglycemia consumed 11% of resources associated with hospital births while accounting for only 1.5 % of hospitalization. This study identified factors associated with increased cost in neonatal hypoglycemia.
Zitieren
APA
(2018). Predictors of Hospitalization Cost in Infants with Hypoglycemia. Journal of Pediatrics & Neonatal Biology. https://doi.org/10.33140/jpnb.03.01.03
Vancouver
Predictors of Hospitalization Cost in Infants with Hypoglycemia. Journal of Pediatrics & Neonatal Biology. 2018. doi:10.33140/jpnb.03.01.03
BibTeX
@article{euvimed2018,
title = {Predictors of Hospitalization Cost in Infants with Hypoglycemia},
journal = {Journal of Pediatrics & Neonatal Biology},
year = {2018},
doi = {10.33140/jpnb.03.01.03}
}
EUVIMED